Healthcare provider profile · identity verified

Bipinchandra M. Patel, MD

Internal Medicine · LOUDON, TN · NPI 1881655066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	570	129
Levothyroxine Sodium	Levothyroxine Sodium	521	114
Lisinopril	Lisinopril	497	130
Amlodipine Besylate	Amlodipine Besylate	485	112
Eliquis	Apixaban	417	60
Omeprazole	Omeprazole	321	95
Metoprolol Tartrate	Metoprolol Tartrate	300	76
Losartan Potassium	Losartan Potassium	296	76
Buspirone Hcl	Buspirone Hcl	282	61
Hydrochlorothiazide	Hydrochlorothiazide	279	77
Metformin Hcl	Metformin Hcl	275	69
Trazodone Hcl	Trazodone Hcl	267	54
Pantoprazole Sodium	Pantoprazole Sodium	261	65
Simvastatin	Simvastatin	261	71
Furosemide	Furosemide	256	73
Sertraline Hcl	Sertraline Hcl	241	48
Clopidogrel	Clopidogrel Bisulfate	229	52
Gabapentin	Gabapentin	222	50
Tamsulosin Hcl	Tamsulosin Hcl	197	47
Famotidine	Famotidine	194	45
Escitalopram Oxalate	Escitalopram Oxalate	190	34
Carvedilol	Carvedilol	181	42
Potassium Chloride	Potassium Chloride	164	41
Rosuvastatin Calcium	Rosuvastatin Calcium	162	40
Donepezil Hcl	Donepezil Hcl	161	38
Memantine Hcl	Memantine Hcl	146	28
Citalopram Hbr	Citalopram Hydrobromide	143	40
Mirtazapine	Mirtazapine	142	25
Prednisone	Prednisone	137	88
Pioglitazone Hcl	Pioglitazone Hcl	125	34
Fluticasone Propionate	Fluticasone Propionate	124	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	124	24
Albuterol Sulfate Hfa	Albuterol Sulfate	119	32
Allopurinol	Allopurinol	117	23
Metoprolol Succinate	Metoprolol Succinate	113	34
Quetiapine Fumarate	Quetiapine Fumarate	113	27
Hydralazine Hcl	Hydralazine Hcl	111	29
Meloxicam	Meloxicam	110	37
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	97	18
Montelukast Sodium	Montelukast Sodium	97	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	20
Ozempic	Semaglutide	93	19
Divalproex Sodium	Divalproex Sodium	87	17
Doxycycline Hyclate	Doxycycline Hyclate	86	70
Tramadol Hcl	Tramadol Hcl	83	17
Pravastatin Sodium	Pravastatin Sodium	79	25
Alprazolam	Alprazolam	77	17
Duloxetine Hcl	Duloxetine Hcl	75	20
Fluoxetine Hcl	Fluoxetine Hcl	71	suppressed
Lamotrigine	Lamotrigine	70	suppressed
Clonidine Hcl	Clonidine Hcl	68	20
Alendronate Sodium	Alendronate Sodium	66	21
Zolpidem Tartrate	Zolpidem Tartrate	65	18
Bumetanide	Bumetanide	64	14
Gemtesa	Vibegron	63	suppressed
Methenamine Hippurate	Methenamine Hippurate	61	11
Ezetimibe	Ezetimibe	60	15
Lovastatin	Lovastatin	59	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	13
Lorazepam	Lorazepam	57	21
Carbamazepine Er	Carbamazepine	55	suppressed
Azithromycin	Azithromycin	54	47
Baclofen	Baclofen	53	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	41
Januvia	Sitagliptin Phosphate	53	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	49	11
Spironolactone	Spironolactone	48	15
Esomeprazole Magnesium	Esomeprazole Magnesium	47	11
Metformin Hcl Er	Metformin Hcl	47	12
Jardiance	Empagliflozin	46	suppressed
Diltiazem Hcl	Diltiazem Hcl	45	suppressed
Atenolol	Atenolol	44	12
Paroxetine Hcl	Paroxetine Hcl	44	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	43	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	21
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Glimepiride	Glimepiride	41	13
Trulicity	Dulaglutide	41	suppressed
Finasteride	Finasteride	40	11
Propranolol Hcl	Propranolol Hcl	40	11
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Cephalexin	Cephalexin	36	33
Olanzapine	Olanzapine	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Ondansetron Odt	Ondansetron	29	11
Primidone	Primidone	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	28	suppressed
Naproxen	Naproxen	28	19
Digoxin	Digoxin	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	19
Nitrofurantoin	Nitrofurantoin Macrocrystal	26	11
Oxcarbazepine	Oxcarbazepine	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Nystatin	Nystatin	24	13
Sucralfate	Sucralfate	24	suppressed
Glipizide	Glipizide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Amoxicillin	Amoxicillin	22	20
Aripiprazole	Aripiprazole	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Movantik	Naloxegol Oxalate	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Topiramate	Topiramate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Levofloxacin	Levofloxacin	17	15
Methocarbamol	Methocarbamol	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Valsartan	Valsartan	17	suppressed
Zonisamide	Zonisamide	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Nitroglycerin Patch	Nitroglycerin	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Theophylline Er	Theophylline Anhydrous	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluconazole	Fluconazole	13	12
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Prilosec	Omeprazole Magnesium	12	suppressed
Propafenone Hcl	Propafenone Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Temazepam	Temazepam	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error